1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: Design, synthesis, structure-affinity and structure-selectivity relationships

被引:26
|
作者
Stefanachi, Angela [1 ]
Nicolotti, Orazio [1 ]
Leonetti, Francesco [1 ]
Cellamare, Saverio [1 ]
Campagna, Francesco [1 ]
Isabel Loza, Maria [2 ]
Manuel Brea, Jose [2 ]
Mazza, Fernando [3 ]
Gavuzzo, Enrico [4 ]
Carotti, Angelo [1 ]
机构
[1] Univ Bari, Dipartimento Farmacochim, I-70125 Bari, Italy
[2] Univ Santiago de Compostela, Dept Farmacol, E-15782 Santiago De Compostela, Spain
[3] Univ Aquila, Dipartimento Chim Ingn Chim & Mat, I-67100 Laquila, Italy
[4] CNR, I-00016 Monterotondo, Rome, Italy
关键词
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines; Adenosine receptor antagonists; Structure-affinity relationships; Structure-selectivity relationships; X-ray crystallography;
D O I
10.1016/j.bmc.2008.09.067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of 1,3-dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines were prepared and evaluated as ligands of recombinant human adenosine receptors (hARs). Several 1,3-dipropyl derivatives endowed with nano-molar binding affinity at hA(2B) receptors, but poor selectivity over hA(2A), hA(1) and hA(3) AR subtypes were identified. A comparison with the corresponding 7-OH- and 7,9-unsubstituted-deazaxanthines revealed that 9-OH-9-deazaxanthines are more potent hA(2B) ligands with lower partition coefficients and higher water solubility compared to the other two congeneric classes of deazaxanthines. An optimization of the para-substituent of the 8-phenyl ring of 9-OH-9-deazaxanthines led to the discovery of compound 38, which exhibited outstanding hA(2B) affinity (Ki = 1.0 nM), good selectivity over hA(2A), hA(1) and hA(3) (selectivity indices = 100, 79 and 1290, respectively) and excellent antagonist potency in a functional assay on rat A(2B) (pA(2B) = 9.33). (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:9780 / 9789
页数:10
相关论文
共 13 条
  • [1] 1,3-Dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships
    Fernandez, Franco
    Caamano, Olga
    Isabel Nieto, M.
    Lopez, Carmen
    Garcia-Mera, Xerardo
    Stefanachi, Angela
    Nicolotti, Orazio
    Isabel Loza, M.
    Brea, Jose
    Esteve, Cristina
    Segarra, Victor
    Vidal, Bernat
    Carotti, Angelo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (10) : 3618 - 3629
  • [2] 8-substituted-9-deazaxanthines as adenosine receptor ligands:: design, synthesis and structure-affinity relationships at A2B
    Carotti, A
    Stefanachi, A
    Raviña, E
    Sotelo, E
    Loza, MI
    Cadavid, MI
    Centeno, NB
    Nicolotti, O
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (10) : 879 - 887
  • [3] Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor
    Carotti, A
    Cadavid, MI
    Centeno, NB
    Esteve, C
    Loza, MI
    Martinez, A
    Nieto, R
    Raviña, E
    Sanz, F
    Segarra, V
    Sotelo, E
    Stefanachi, A
    Vidal, B
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (01) : 282 - 299
  • [4] 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor
    Stefanachi, Angela
    Brea, Jose Manuel
    Cadavid, Maria Isabel
    Centeno, Nuria B.
    Esteve, Cristina
    Loza, Maria Isabel
    Martinez, Ana
    Nieto, Rosa
    Ravina, Enrique
    Sanz, Ferran
    Segarra, Victor
    Sotelo, Eddy
    Vidal, Bernat
    Carotti, Angelo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (06) : 2852 - 2869
  • [5] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF DEAZAXANTHINES - ANALOGS OF POTENT A(1-)-ADENOSINE AND A(2)-ADENOSINE RECEPTOR ANTAGONISTS
    GRAHNER, B
    WINIWARTER, S
    LANZNER, W
    MULLER, CE
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (10) : 1526 - 1534
  • [6] 1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor (vol 16, pg 2852, 2008)
    Stefanachi, Angela
    Brea, Jose Manuel
    Cadavid, Maria Isabel
    Centeno, Nuria B.
    Esteve, Cristina
    Loza, Maria Isabel
    Martinez, Ana
    Nieto, Rosa
    Ravina, Enrique
    Sanz, Ferran
    Segarra, Victor
    Sotelo, Eddy
    Vidal, Bernat
    Carotti, Angelo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (18) : 8766 - 8766
  • [7] 2-alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists:: Their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A2B receptor
    Harada, H
    Asano, O
    Hoshino, Y
    Yoshikawa, S
    Matsukura, M
    Kabasawa, Y
    Niijima, J
    Kotake, Y
    Watanabe, N
    Kawata, T
    Inoue, T
    Horizoe, T
    Yasuda, N
    Minami, H
    Nagata, K
    Murakami, M
    Nagaoka, J
    Kobayashi, S
    Tanaka, I
    Abe, S
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (02) : 170 - 179
  • [8] Novel 1,3-dipropyl-8-(4-(phenyloxadiazolyl)methoxy)phenyl xanthines: A2B adenosine receptor antagonists with high affinity and selectivity.
    Zablocki, J
    Kalla, R
    Perry, T
    Palle, V
    Varkhedkar, V
    Xiao, DM
    Piscopio, AD
    Wu, YZ
    Maydanik, V
    Maa, T
    Nguyen, M
    Lustig, D
    Leung, K
    Zeng, DW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U52 - U53
  • [9] Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor1 receptor antagonists
    Nakazato, A
    Kumagai, T
    Okubo, T
    Tanaka, H
    Chaki, S
    Okuyama, S
    Tomisawa, K
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (05) : 1183 - 1193
  • [10] 1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies
    Catarzi, Daniela
    Varano, Flavia
    Poli, Daniela
    Squarcialupi, Lucia
    Betti, Marco
    Trincavelli, Letizia
    Martini, Claudia
    Dal Ben, Diego
    Thomas, Ajiroghene
    Volpini, Rosaria
    Colotta, Vittoria
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (01) : 9 - 21